Skip to main content

Sara Garcia Ortega

Institutions of which they are part

Predoctoral researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Sara Garcia Ortega

Institutions of which they are part

Predoctoral researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

MNK - EB1

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Inés de Torres Ramirez, Adriana Martinez Cifuentes, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Vicente Peg Camara, Stefan Hummer
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 189970
Reference: SLT036/24/000026
Duration: 21/12/2024 - 20/12/2026

The MNK inhibitor EB1: a novel opportunity to combat therapy resistance in cancer treatment

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Inés de Torres Ramirez, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Vicente Peg Camara, Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 149347
Reference: 2024 PROD 00056
Duration: 02/12/2024 - 01/06/2026

inhibición de la comunicación celular para la prevención del desarrollo de metástasis y la resistencia a terapias antitumorales. Desarrollo de dos nuevas aproximaciones terapéuticas

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Josep Castellví Vives, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Javier Hernandez Losa, Marta Sese Faustino, Lourdes Elena Salazar Huayna, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 240000
Reference: PI23/01754
Duration: 01/01/2024 - 31/12/2026

x

IP: Laia Perez Lasarte
Collaborators: Sara Garcia Ortega
Funding agency: Fundació Institut de Recerca HUVH
Funding: 55810.89
Reference: VHIR/PHDPROGRAMME/2022/GARCIA
Duration: 01/06/2022 - 30/09/2025

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Melek Denizli

Melek Denizli

Research technician
Biomedical Research in Gynaecology
Read more
Anastasia Culea

Anastasia Culea

Research assistant
General Surgery
Read more
Elizabeth Barba Orozco

Elizabeth Barba Orozco

Physiology and Pathophysiology of the Digestive Tract
Read more
Filipa Xavier De Carvalho Negrao Valente

Filipa Xavier De Carvalho Negrao Valente

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.